Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF biomarkers.

CONCLUSION: AD diagnosis (MCI or dementia) with normal CSF biomarkers is a rare condition. A clinical follow-up is particularly recommended to consider an alternative diagnosis. PMID: 29318973 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29318973?dopt=Abstract

Source: Current Alzheimer Research - January 9, 2018 Category: Neurology Authors: Vercruysse O, Paquet C, Gabelle A, Delbeuck X, Blanc F, Wallon D, Dumurgier J, Magnin E, Martinaud O, Jung B, Bousiges O, Lehmann S, Delaby C, Quillard-Murain M, Peoc'h K, Laplanche JL, Bouaziz-Amar E, Hannequin D, Sablonniere B, Buee L, Hugon J, Schraen Tags: Curr Alzheimer Res Source Type: research